Available evidence indicates that CeAD accompanied by ischemic stroke is associated with higher plasma levels of hepatocyte growth factor (HGF) and stromal cell-derived factor 1α (SDF-1α) as well as lower IL-4 concentrations, reflecting a more pronounced systemic inflammatory activation [20]. The gene discussed is HGF; the disease is ischemic stroke.